ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 86 filers reported holding ENZO BIOCHEM INC in Q2 2020. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $352,000 | -17.6% | 102,282 | -39.6% | 0.00% | -33.3% |
Q4 2020 | $427,000 | +55.3% | 169,430 | +29.9% | 0.00% | -25.0% |
Q3 2020 | $275,000 | +848.3% | 130,462 | +896.7% | 0.00% | – |
Q2 2020 | $29,000 | -85.0% | 13,089 | -82.2% | 0.00% | -100.0% |
Q4 2019 | $193,000 | -14.2% | 73,442 | +17.7% | 0.00% | -50.0% |
Q3 2019 | $225,000 | -39.2% | 62,387 | -43.2% | 0.00% | -50.0% |
Q2 2019 | $370,000 | -38.3% | 109,776 | -50.1% | 0.00% | -33.3% |
Q1 2019 | $600,000 | +6.2% | 219,952 | +8.1% | 0.01% | -14.3% |
Q4 2018 | $565,000 | -4.9% | 203,402 | +41.2% | 0.01% | 0.0% |
Q3 2018 | $594,000 | +53.9% | 144,056 | +93.6% | 0.01% | +40.0% |
Q2 2018 | $386,000 | +75.5% | 74,400 | +85.1% | 0.01% | +66.7% |
Q1 2018 | $220,000 | -29.9% | 40,198 | +4.3% | 0.00% | -40.0% |
Q4 2017 | $314,000 | -34.9% | 38,524 | -16.3% | 0.01% | -44.4% |
Q3 2017 | $482,000 | +282.5% | 46,000 | +303.5% | 0.01% | +350.0% |
Q2 2017 | $126,000 | +61.5% | 11,400 | +1.4% | 0.00% | -33.3% |
Q4 2016 | $78,000 | – | 11,238 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |